Pharmaceutical / Drug Definition :
Inhibits cholinergic excitatory pathways and restores balance of dopamine and acetylcholine in CNS, thereby decreasing excess salivation, rigidity, and tremors (parkinsonian symptoms)
FDA Label Requirements and Exceptions
Benztropine Mesylate
FDA Import Information
Benztropine Mesylate
FDA Detentions
Benztropine Mesylate (Benztropine Mesylate Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Benztropine Mesylate (Benztropine Mesylate Suppliers)
- Processors Benztropine Mesylate
- Repackers Benztropine Mesylate
- Relabelers Benztropine Mesylate
- Exporters Benztropine Mesylate
- Importers Benztropine Mesylate
For more information about Benztropine Mesylate, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
